1. Type I interferon induced during chronic viral infection favors B-cell development in the thymus.
- Author
-
Valbon SF, Lebel ME, Feldman HA, Condotta SA, Dong M, Giordano D, Waggoner SN, Melichar HJ, and Richer MJ
- Subjects
- Animals, Mice, Inbred C57BL, Mice, Signal Transduction, Chronic Disease, B-Cell Activating Factor metabolism, Persistent Infection immunology, Persistent Infection virology, Thymus Gland immunology, Thymus Gland virology, B-Lymphocytes immunology, B-Lymphocytes virology, Lymphocytic Choriomeningitis immunology, Lymphocytic Choriomeningitis virology, Interferon Type I metabolism, Lymphocytic choriomeningitis virus immunology, Lymphocytic choriomeningitis virus physiology, Cell Differentiation
- Abstract
Chronic viral infections cause thymic involution yet the potential for broader, longer-term impact on thymic composition remains unexplored. Here we show that chronic, but not acute, lymphocytic choriomeningitis virus infection promotes a unique population of immature B cells in the thymus. We show that chronic viral infection promotes signals within the thymus, including the expression of B-cell activating factor (BAFF), that favor the maturation of this population as these cells acquire expression of CD19 and immunoglobulin M. Mechanistically, type I interferon (IFN-I), predominantly IFNβ, signals to thymic hematopoietic cells, strongly delaying T-cell development at the earliest precursor stage. Furthermore, IFN-I signaling to the nonhematopoietic compartment provides a second signal essential to favor B-cell differentiation and maturation within the thymus. Importantly, chronic infection yields changes in the B-cell population for at least 50 days following infection, long after thymic atrophy has subsided. Thus, the inflammatory milieu induced by chronic viral infection has a profound, and long-lasting, effect on thymic composition leading to the generation of a novel population of thymic B cells., (© 2024 The Author(s). Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of the Australian and New Zealand Society for Immunology, Inc.)
- Published
- 2024
- Full Text
- View/download PDF